U.S. market Closed. Opens in 3 hours 27 minutes

BDRX | Biodexa Pharmaceuticals Plc Stock Overview

(Stock Exchange: NASDAQ)
*Chart delayed
Analyzing fundamentals for BDRX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see BDRX Fundamentals page.

More technicals details can be found on BDRX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙